Xilai Ma

No ORCID on file · 1 paper in corpus

other 2024

Pharmacological targets of SGLT2 inhibition on prostate cancer mediated by circulating metabolites: a drug-target Mendelian randomization study

Frontiers in pharmacology ·doi:10.3389/fphar.2024.1443045

BACKGROUND: The relationship between sodium-glucose cotransporter 2 (SGLT2) inhibitors and prostate cancer is still unknown. Although these inhibitors can influence tumor glycolysis, the underlying mechanism requires further exploration. M…